Curium Announces Last Patient Enrolled in Their Phase 1/2 SOLAR Clinical Trial Imaging Men with Histologically-Proven Metastatic Prostate Cancer Using Copper Cu 64 PSMA I&T.
May 23, 2023 12:57 ET
|
Curium
PARIS, May 23, 2023 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has completed enrollment in its USA-led SOLAR Phase 1/2 study evaluating the safety,...
Medical Imaging Market Generate Revenue Of $48.8 Billion (+CAGR Of 5.4%) Worldwide by 2032 - Exclusive Report By Market.us
May 17, 2023 02:54 ET
|
Market.Us
New York, May 17, 2023 (GLOBE NEWSWIRE) -- The medical imaging market size is expected to be worth around USD 48.8 Bn by 2032 from USD 29.2 Bn in 2022, growing at a CAGR of 5.4% during the forecast...
Global Nuclear Medicine Market Size To Worth USD 24.9 Billion By 2030 | CAGR of 13.8%
May 15, 2023 16:30 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , May 15, 2023 (GLOBE NEWSWIRE) -- The Global Nuclear Medicine Market Size to grow from USD 9.2 Billion in 2021 to USD 24.9 Billion by 2030, at a Compound Annual Growth Rate...
Novel Workflow Approaches Create Significant Opportunities in Radiopharmaceuticals Market, as per TMR Study
May 15, 2023 06:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 15, 2023 (GLOBE NEWSWIRE) -- According to TMR market research, the global radiopharmaceuticals industry growth is expected to be robust owing to rise in...
Global Alpha Emitter Market Report 2023: Sector is Expected to Reach $1,181.9 Million by 2030 at a CAGR of 13.8%
April 20, 2023 05:58 ET
|
Research and Markets
Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Alpha Emitter Market, By Type of Radionuclide, By Medical Applications, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023-2030"...
Curium Confirms No Supply Challenges in North America and Europe for its Eclipse Phase 3 Clinical Trial
March 14, 2023 10:46 ET
|
Curium
To date, an uninterrupted supply of 177Lu-PSMA-I&TRobust supply chains and global transportation infrastructure deliver supply securityCurium’s clinical trials play central role in innovations in...
Global Nuclear Medicine Imaging Equipment Strategic Report 2023: PET-MRI Emerging as a Promising Standard for Imaging Soft Tissue Contrast
March 07, 2023 12:13 ET
|
Research and Markets
Dublin, March 07, 2023 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Imaging Equipment: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
Nuclear Medicine Market Size Worth USD 19.47 Billion by 2028 | Report by Fortune Business Insights
January 18, 2023 04:34 ET
|
Fortune Business Insights
Pune, India, Jan. 18, 2023 (GLOBE NEWSWIRE) -- The global nuclear medicine market size was valued at USD 5.04 billion in 2020 and USD 5.57 billion in 2021. The market is expected to reach USD 19.47...
Nuclear Medicine Global Market Report 2022: Featuring Bracco Imaging, NTP Radioisotopes, GE Healthcare & More
December 22, 2022 07:08 ET
|
Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "Nuclear Medicine Global Market Report 2022: Ukraine-Russia War Impact" report has been added to ResearchAndMarkets.com's offering.The global nuclear...
Curium’s 14 Million Patients to Benefit From Regular Supply of Mo-99 and Tc-99
December 21, 2022 10:26 ET
|
Curium
PARIS, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Curium, the world’s leading nuclear medicine company, announced today that with the successful restarting of the BR2 research reactor in Belgium on 20...